Trial results fail to support fluoxetine for stroke recovery
But specialists in neurorehabilitation suggest better-designed studies could yield a different outcome
Data from three similar trials of daily fluoxetine for functional recovery after stroke provide compelling evidence that the agent should not be routinely prescribed after acute stroke, researchers say.